CISPLATINE VIATRIS 25 mg/25 ml, concentrate for solution for infusion bottle, 25 ml
Active ingredients: Cisplatin
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 25 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CISPLATINE VIATRIS 25 mg/25 ml, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre brun de 25 ml avec ou sans suremballée(s)/surpochée(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Mar 2000
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69042418CIP75622522CIP133400956225224Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CISPLATINEsolution | 25 mg · 25 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.